MAXIM PHARMACEUTICALS INC — SEC financials & events

Financials

SEC XBRL · annual

No structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).

Insider transactions

SEC Form 4 · most recent

0 acquisitions5 disposalsnet −282,593 shares · last 5

Insider	Date	Type	Shares	Price
Martensson PerolafDirector	Jan 4, 2006	D	333	—
Prunty John DOfficer — Chief Financial Officer	Jan 4, 2006	D	4,042	—
Townsen Fulton DuwaineDirector	Jan 4, 2006	D	71,228	—
Stambaugh Larry GOfficer — Chairman,CEO and President	Jan 4, 2006	D	3,657	—
Stambaugh Larry GOfficer — Chairman,CEO and President	Aug 3, 2005	D	203,333	$1.46

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

4Jan 6, 2006
4Jan 6, 2006
4Jan 6, 2006
4Jan 6, 2006
4Jan 6, 2006
4Jan 6, 2006
4Jan 6, 2006
15-12BTERMINATION OF REGISTRATION OF SECURITIES UNDER SECTION 12(B)Jan 5, 2006
8-KCURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGESDec 21, 2005
10-KANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D)Dec 14, 2005
DEFA14ADec 14, 2005
8-KCURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGESDec 14, 2005
DEFA14ADec 8, 2005
DEFA14ADec 8, 2005
DEFA14ADEFINITIVE ADDITIONAL MATERIALSDec 5, 2005

Event-driven situations (1)

Nov 10, 2005Merger / acquisition (shareholder vote)completed